A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
- 2 May 2014
- journal article
- case report
- Published by Informa UK Limited in Drug Delivery
- Vol. 23 (1), 167-173
- https://doi.org/10.3109/10717544.2014.908248
Abstract
Inadequate penetration of the blood-brain barrier (BBB) by systemically administered chemotherapies including carboplatin is implicated in their failure to improve prognosis for patients with glioblastoma. Convection-enhanced delivery (CED) of carboplatin has the potential to improve outcomes by facilitating bypass of the BBB. We report the first use of an implantable CED system incorporating a novel transcutaneous bone-anchored port (TBAP) for intermittent CED of carboplatin in a patient with recurrent glioblastoma. The CED catheter system was implanted using a robot-assisted surgical method. Catheter targeting accuracy was verified by performing intra-operative O-arm imaging. The TBAP was implanted using a skin-flap dermatome technique modeled on bone-anchored hearing aid surgery. Repeated infusions were performed by attaching a needle administration set to the TBAP. Drug distribution was monitored with serial real-time T2-weighted magnetic resonance imaging (MRI). All catheters were implanted to within 1.5 mm of their planned target. Intermittent infusions of carboplatin were performed on three consecutive days and repeated after one month without the need for further surgical intervention. Infused volumes of 27.9 ml per day were well tolerated, with the exception of a single seizure episode. Follow-up MRI at eight weeks demonstrated a significant reduction in the volume of tumor enhancement from 42.6 ml to 24.6 ml, and was associated with stability of the patient's clinical condition. Reduction in the volume of tumor enhancement indicates that intermittent CED of carboplatin has the potential to improve outcomes in glioblastoma. The novel technology described in this report make intermittent CED infusion regimes an achievable treatment strategy.Keywords
This publication has 24 references indexed in Scilit:
- Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem gliomaActa Neurochirurgica, 2013
- Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored portJournal of Neuroscience Methods, 2013
- The development of an implantable catheter system for chronic or intermittent convection-enhanced deliveryJournal of Neuroscience Methods, 2012
- Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of TopotecanNeurosurgery, 2011
- Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced deliveryJournal of Neurosurgery, 2011
- AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiformeAdvances in Therapy, 2011
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyNeuro-Oncology, 2010
- Intra-arterial carboplatin chemotherapy for brain tumors: A dose escalation study based on cerebral blood flowJournal of Neuro-Oncology, 1997
- Convection-enhanced delivery of macromolecules in the brain.Proceedings of the National Academy of Sciences of the United States of America, 1994
- High-dose Carboplatin in Combination with Etoposide (JET Regimen) for Childhood Brain TumorsJournal of Pediatric Hematology/Oncology, 1990